PNTG
The Pennant Group, Inc.NASDAQHealthcare$29.66+0.88%ClosedMarket Cap: $1.03B
As of 2026-04-06
Valuation
P/E (TTM)
34.76
PEG
1.12
P/B
3.12
P/S
1.09
EV/EBITDA
24.21
DCF Value
$-8.60
FCF Yield
3.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
15.1%
Operating Margin
5.5%
Net Margin
3.1%
ROE
9.3%
ROA
3.1%
ROIC
4.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $289.3M | 12.9% | $18.1M | $8.6M | $0.24 | — |
| FY 2025 | $947.7M | 12.9% | $51.4M | $29.6M | $0.84 | — |
| Q3 2025 | $229.0M | 20.2% | $10.2M | $6.1M | $0.17 | — |
| Q2 2025 | $219.5M | 13.8% | $11.5M | $7.1M | $0.20 | — |
| Q1 2025 | $209.8M | 14.0% | $12.7M | $7.8M | $0.22 | — |
| Q4 2024 | $188.9M | 13.2% | $9.2M | $5.8M | $0.16 | — |
| FY 2024 | $695.2M | 13.5% | $38.1M | $22.6M | $0.71 | — |
| Q3 2024 | $180.7M | 14.0% | $10.8M | $6.2M | $0.20 | — |
| Q2 2024 | $168.7M | 13.6% | $9.6M | $5.7M | $0.18 | — |
| Q1 2024 | $156.9M | 13.1% | $8.5M | $4.9M | $0.16 | — |
| Q4 2023 | $146.0M | 12.8% | $7.6M | $4.3M | $0.14 | — |
| FY 2023 | $544.9M | 12.3% | $25.2M | $13.4M | $0.44 | — |